DOI: 10.12890/2025_005706
A very rare SETX gene variant (c.2750T>C) in a 72-year-old man with amyotrophic lateral sclerosis and an unremarkable family history. Should genetic testing be routinely performed in all patients?
Authors
andreas.posa@medizin.uni-halle.de
Keywords
Amyotrophic lateral sclerosis, motor neurone disease, neurodegenerative multisystem disease, SETX gene, senataxin proteinAbstract
Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative multisystem disease with loss of spinal, bulbar and cortical upper and lower motor neurons resulting in progressive and generalised paralysis. Unfortunately, many aspects of this disease remain unclear. In the age of next generation sequencing, numerous gene variants have been discovered that are associated with ALS. In this article, a 72-year-old male underwent a medical history interview, clinical neurological examinations, neuropsychological tests, electrophysiological examinations (electromyography, electroneurography, somatosensory evoked potentials), computed tomography scan of the head and the cervical spine, blood and cerebrospinal fluid tests and a genetic analysis. The results of these examinations provided the definitive diagnosis of ALS. Whole-exome sequencing revealed the very rare genetic finding of the SETX Class-4 variant c.2750T>C (p.Met917Thr). The case presented here discusses the role of the SETX gene as a possible pathogenetic variant of adult-onset ALS. It demonstrates the relevance of genetic screening for gene variants of ALS in routine diagnostics. The precise classification of disease-related gene variants is of great relevance for clinical practice.
References
- González-Sánchez M, Ramírez-Expósito MJ, Martínez-Martos JM. Pathophysiology, clinical heterogeneity, and therapeutic advances in amyotrophic lateral sclerosis: A comprehensive review of molecular mechanisms, diagnostic challenges, and multidisciplinary management strategies. Life 2025;15:647. doi: 10.3390/life15040647
- Bennett CL, La Spada AR. SUMOylated Senataxin functions in genome stability, RNA degradation, and stress granule disassembly, and is linked with inherited ataxia and motor neuron disease. Mol Genet Genomic Med 2021;9:e1745. doi: 10.1002/mgg3.1745
- Lei L, Chen H, Lu Y, Zhu W, Ouyang Y, Duo J, et al. Unusual electrophysiological findings in a Chinese ALS 4 family with SETX-L389S mutation: a three-year follow-up. J Neurol 2021;268:1050-1058. doi: 10.1007/s00415-020-10246-2
- Kannan A, Cuartas J, Gangwani P, Branzei D, Gangwani L. Mutation in senataxin alters the mechanism of R-loop resolution in amyotrophic lateral sclerosis 4. Brain 2022;145:3072-3094. doi: 10.1093/brain/awab464
- Pensato V, Magri S, Dalla Bella E, Tannorella P, Bersano E, Sorarù G, et al. Sorting rare ALS genetic variants by targeted re-sequencing panel in Italian patients: OPTN, VCP, and SQSTM1 variants account for 3% of rare genetic forms. J Clin Med 2020;9:412. doi: 10.3390/jcm9020412
- Picher-Martel V, Brunet F, Dupré N, Chrestian N. The occurrence of FUS mutations in pediatric amyotrophic lateral sclerosis: a case report and review of the literature. J Child Neurol 2020;35:556-562. doi: 10.1177/0883073820915099
- Hadjinicolaou A, Ngo KJ, Conway DY, Provias JP, Baker SK, Brady LI, et al. De novo pathogenic variant in SETX causes a rapidly progressive neurodegenerative disorder of early childhood-onset with severe axonal polyneuropathy. Acta Neuropathol Commun 2021;9:194. doi: 10.1186/s40478-021-01277-5
- Grassano M, Calvo A, Moglia C, Sbaiz L, Brunetti M, Barberis M, et al. Systematic evaluation of genetic mutations in ALS: a population-based study. J Neurol Neurosurg Psychiatry 2022;93:1190-1193. doi: 10.1136/jnnp-2022-328931
- Finsterer J, Stöllberger C, Keller H, Laccone F. Variants in HNRNPDL and SETX not necessarily indicate familial amyotrophic lateral sclerosis or limb girdle muscular dystrophy 1G in acute muscular respiratory failure. J Neurosci Rural Pract 2020;11:353-354. doi: 10.1055/s-0040-1709375
